Technical aspects of SEEG limitations and solutions using the Leksell Vantage frame - Top-Institutions - MDSpire

Technical aspects of SEEG limitations and solutions using the Leksell Vantage frame

  • By

  • Insa Prilop

  • Stephan B. Sobottka

  • Georg K. Leonhardt

  • Ilker Y. Eyüpoglu

  • Witold H. Polanski

  • October 27, 2025

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Epilepsy Center
    University of California, San Francisco (UCSF) Epilepsy Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Epileptology
    • Neuroimaging

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurosurgery
    • Epileptology
    • Neurophysiology

  • #3

    Cleveland Clinic Epilepsy Center
    Cleveland Clinic Epilepsy Center

    Cleveland, OH

    Key Differentiators

    • Neurosurgery
    • Epileptology
    • Neuroimaging

  • #4

    National Institute of Neurological Disorders and Stroke (NINDS), NIH
    National Institute of Neurological Disorders and Stroke (NINDS), NIH

    Bethesda, MD

    Key Differentiators

    • Neurosurgery
    • Neurology
    • Neuroengineering

  • #5

    Hôpital de la Pitié-Salpêtrière
    Hôpital de la Pitié-Salpêtrière

    Paris, Île-de-France

    Key Differentiators

    • Neurosurgery
    • Epileptology
    • Neurophysiology

Original Source(s)

Technical aspects of SEEG limitations and solutions using the Leksell Vantage frame

  • by Insa Prilop, Stephan B. Sobottka, Georg K. Leonhardt, Ilker Y. Eyüpoglu, Witold H. Polanski

  • October 27, 2025

Related Content

Language Processing Persists Under Anesthesia

Intraoperative recordings suggested preserved processing of speech and auditory context during unconsciousness.

Impact of onset timing and operative duration on outcomes in chronic subdural hematoma: an exploratory retrospective study

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.